[1] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[2] 巢世红,巢世兰.降压药物联合高压氧治疗原发性高血压及减少并发症的临床效果分析[J].东南大学学报(医学版),2017,36(5):776-780.
[3] 黄娅茜,唐朝枢,杜军保,等.含硫气体信号分子对心血管调节的效应及机制研究进展[J].生理科学进展,2017,48(1):4-11.
[4] KATAOKA T,HOTTA Y,MAEDA Y,et al.Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats[J].J Sex Med,2017,14(12):1540-1548.
[5] 才让卓玛,薛林燕,刘君,等.组织多普勒Tei指数对高海拔地区特发性肺动脉高压患者右心功能的评价[J].现代医学,2018,46(9):983-987.
[6] TAIN Y L,HSU C N.Targeting on asymmetric dimethylarginine-related nitric oxide-reactive oxygen species imbalance to reprogram the development of hypertension[J].Int J Mol Sci,2016,17(12):e2020.
[7] HU X,XU X,ZHU G,et al.Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine[J].Circulation,2009,120(22):2222-2229.
[8] 林丽艳,张慧云,何韶衡.IL-6及其受体与炎症性疾病关系的新进展[J].中国热带医学,2008(4):680-682.
[9] CAI Z,LI J,ZHUANG Q,et al.MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways[J].Exp Mol Med,2018,50(4):45.
[10] REDDY S S,CHAUHAN P,MAURYA P,et al.Coagulin-L ameliorates TLR4 induced oxidative damage and immune response by regulating mitochondria and NOX-derived ROS[J].Toxicol Appl Pharmacol,2016,309:87-100.
[11] LI F,SHI W,WAN Y,et al.Prediction of target genes for miR-140-5p in pulmonary arterial hypertension using bioinformatics methods[J].FEBS Open Bio,2017,7(12):1880-1890. |